ID   HCE-2
AC   CVCL_3316
SY   50.B1
DR   CLO; CLO_0003662
DR   ATCC; CRL-3582
DR   ATCC; CRL-11135
DR   BioSample; SAMN03471330
DR   Wikidata; Q54881847
RX   Patent=US5672498;
WW   https://www.atcc.org/en/support/technical-support/faqs/morphology-of-atcc-crl-11135
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11135.
CC   Population: African American.
CC   Doubling time: ~30 hours (ATCC=CRL-3582).
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Discontinued: ATCC; CRL-11135; true.
CC   Derived from site: In situ; Eye, cornea, epithelium; UBERON=UBERON_0001772.
ST   Source(s): ATCC=CRL-3582
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 6,9
ST   TPOX: 10,11
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
RX   Patent=US5672498;
RA   Walker T.L., Kahn C.R.;
RT   "Human corneal epithelial cell lines with extended lifespan.";
RL   Patent number US5672498, 30-Sep-1997.
//